Bausch & Lomb CORP Form 4 insider transactions
NYSE
Andrew J. Stewart, President, Global Pharmaceuticals and International Consumer at Bausch & Lomb Corp, reports disposition of shares to cover tax obligations upon vesting of restricted share units.
NYSE
Robert D. Bailey, EVP & Chief Legal Officer of Bausch & Lomb Corp, disposed of 9,838 common shares on April 24, 2024, to cover tax withholding obligations.
NYSE
Director Russel C. Robertson acquired 1,481 common shares of Bausch & Lomb Corp on March 29, 2024.
NYSE
Director John Paulson increased his holdings in Bausch & Lomb through the acquisition of restricted share units.
NYSE
Director Richard U De Schutter reports acquiring 1,553 common shares of Bausch & Lomb Corp at $17.30 per share on March 29, 2024.
NYSE
Director Karen Ling acquired 2,642 common shares of Bausch & Lomb Corp through a restricted stock unit (RSU) grant.
NYSE
Yehia Hashad, EVP of R&D and CMO at Bausch & Lomb, reports a transaction involving common shares to cover tax obligations.
NYSE
Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp, sold 995 common shares on March 1, 2024, to cover tax obligations arising from vesting restricted share units.
NYSE
Form 4: Bausch & Lomb Executive Reports Stock Transaction Following Vesting of Restricted Share Units
Luc Bonnefoy, President, Surgical at Bausch & Lomb, reports disposition of shares to cover tax obligations upon vesting of restricted share units.
NYSE
Sam Eldessouky, EVP and CFO of Bausch & Lomb, reports the disposition of 4,854 common shares to cover tax obligations upon vesting of restricted share units on March 1, 2024.
NYSE
Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp, reports acquiring and disposing of common shares, including the grant of restricted stock units.
NYSE
Yehia Hashad, EVP of R&D and CMO at Bausch & Lomb, reports the acquisition of restricted stock units and stock options.
NYSE
Luc Bonnefoy, President of Surgical at Bausch & Lomb, reports acquisition of stock options and restricted stock units.
NYSE
Andrew J. Stewart, a Bausch & Lomb executive, was granted stock options and restricted stock units (RSUs) under the company's 2022 Omnibus Incentive Plan.
NYSE
Sam Eldessouky, EVP and CFO of Bausch & Lomb, reports the acquisition of restricted stock units and stock options.
NYSE
CEO Brent Saunders reports receiving restricted stock units and stock options from Bausch & Lomb on February 28, 2024.
NYSE
EVP and Chief Legal Officer A. Robert D. Bailey reports acquisition of restricted stock units and stock options in Bausch & Lomb Corp.